The global checkpoint inhibitor refractory cancer treatment market size reached US$ 35.6 billion in 2023. The market to reach US$ 89.6 billion in 2032, exhibiting a growth rate (CAGR) of 10.8% during 2024-2032.
Explore more: https://www.reportsandinsights.com/report/checkpoint-inhibitor-refractory-cancer-treatment-market